State of Digital Health 2024 Report
From AI’s ascendance to cautious dealmaking, we break down the trends reshaping digital health in 2024 using CB Insights data.
From AI’s ascendance to cautious dealmaking, we break down the trends reshaping digital health in 2024 using CB Insights data.
Pharma giants and diagnostic testing leaders looking to expand in cancer detection should watch high-momentum liquid biopsy startups like Harbinger Health and Delfi Diagnostics.
We mined Roche’s acquisitions, investments, and partnerships to discern the company's strategic priorities. Here’s what pharma and diagnostics companies need to pay attention to.
From in-home humanoids to autonomous labs, we highlight the growing opportunities in robotics markets for providers and other healthcare stakeholders.
We mined Mayo Clinic’s investments to determine how AI is shaping the next generation of healthcare.
While global funding falls, M&A activity picks up in digital health.
We analyzed Eli Lilly’s tech-focused acquisitions, investments, and partnerships to discern the company’s strategic priorities.
Healthcare incumbents, big tech, and startups alike are using AI to address key pain points in clinical workflows. We break down the fast-growing market for ambient AI solutions in healthcare.
From rapid, on-site diagnostics to novel stem cell therapies, animal health is seeing a wave of innovations to prevent, diagnose, and treat disease.
Bet on the right digital health markets. Dig into your rivals’ health tech strategies. Identify the best digital health startups.
In 2024 so far, Andreessen Horowitz’s leading AI priorities are multimedia generation and AI-fueled agents & copilots.
Funding in digital health drops, but larger check sizes and an uptick in exits highlight bright spots for the industry in Q2’24.
Assess how prepared US health systems are to adopt and respond to rapidly evolving AI technologies.
Tech leaders are aggressively applying cloud computing and generative AI to tackle issues in healthcare. We look at how 4 tech giants are building their positions in the industry using strategic investments, partnerships, and product launches.
This report uses the CB Insights TECH Framework to rank femtech markets based on current commercial readiness and momentum.
While digital health funding rebounds in Q1'24, deal count hits a multi-year low.
We analyzed early-stage investment trends to uncover which digital health markets — from tele-psychiatry to virtual & hybrid women's healthcare — are quickly evolving and how these will impact the space.
In 2023, digital health funding and deals continue to plummet from pandemic highs.
From protein design to synthetic patient data, we break down the categories of tech vendors bringing generative AI into the research and clinical settings.
We mined Nvidia's investments and partnerships to discern the company’s strategic priorities in healthcare.
AI companies are dominating funding to the RPM space, attracting strategic interest from investors and health systems alike. We break down the opportunity across funding trends, patent activity, and more.
We mined Bayer’s acquisitions, investments, and partnerships to discern the company's strategic priorities.
From tele-psychiatry providers to mental health chatbots, we break down the categories of vendors expanding access to mental health services.
From at-home fertility testing to non-invasive glucose monitoring, we break down the tech vendors enabling providers to assess and manage patients' health remotely.
From AI-powered liquid biopsies to clinical decision support, we break down the vendors aiming to transform cancer care, diagnosis, and treatment.
We mined Mayo Clinic’s investments and partnerships to discern the company's strategic priorities.